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The efflux of PHJpurines from cultured sympathetic neurons prelabelled with PH]adenine is accelerated 2-3-fold within 
hours of nerve growth factor (NGF) withdrawal and is reduced by readdition of NGF. Addition of 8-(4-chlo~henyl-Rio) 
CAMP, which delays neurite degeneration, reduced the enhanced efflux of purines, as did the addition of cycloheximide, 
MgCI, and the protease inhibitor tosyl-L-lysine chloromethyl ketone. Colchicine accelerated purine efflux and neurite 
degeneration but 2-deoxyglucose increased purine efflux without inducing degeneration, suggesting that ATP reduction 
itself is not the cause of neurite degeneration. The increase in purine efflux is thus an early biochemical event that has 
diagnostic value for the study of NGF action since deprivation is detected well before irreversible changes become 
established. 
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1. INTRODUCTION 
Nerve growth factor (NGF) is a neurotrophic 
factor that supports the survival of sympathetic 
neurons in vivo [I ,2] and in vitro and promotes 
neurite outgrowth from normal and transformed 
neural crest derived neurons [3] in vitro. The 
mechanism of NGF action is only partially 
characterised (for reviews, see [4-61). When NGF 
is withdrawn from neurite-bearing sympathetic 
neurons in culture, a sequence of degenerative 
events occurs, first evident by changes in neurite 
morphology and followed by the degradation and 
death of the cell body. Inhibitors of protein and 
RNA synthesis have been shown to delay degenera- 
tion for 2-3 days if added within 12 h of NGF 
withdrawal 171, implying that specific proteins ac- 
tively promote degeneration. Degeneration may 
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also be blocked for several days with cyclic AMP 
analogues following NGF withdrawal [8]. To begin 
an analysis of the biochemistry of neurite degrada- 
tion, we looked for a simple, noninvasive assay 
that would indicate the absence of NGF before 
overt signs of degeneration are apparent. We have 
shown previously [9] that in sympathetic neurons 
the amount of [3H]ATP produced metabolically 
from [jH]adenine is proportional to neurite 
outgrowth and neurite ATP concentrations change 
in response to metabolic pressures and demands. A 
decrease in ATP is compensated by increases in 
AMP/IMP, causing the generation and efflux of 
labelled purine nucleosides and bases into the 
medium. Since ATP is crucial for axonal transport 
and maintenance of neurite functions [lo-121, we 
decided to test whether changes in ATP concentra- 
tion occurred as a result of NGF withdrawal and if 
so, whether the release of labelled purines could be 
developed into an assay of NGF deprivation. 
2. MATERIALS AND METHODS 
Sympathetic neurons were isolated from superior cervical 
ganglia of 1 day postnatal rats by incubating the desheathec 
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ganglia in a solution of 0.1% trypsin (Difco 1: 250) containing 
0.4 mM EDTA, 140 mM NaCl, 3.5 mM KCl, 10 mM 
phosphate buffer at pH 7.4 and 1 pgfml DNase I (Sigma) for 
30 min at 37°C. The ganglia were washed in modified L15 (Gib- 
co)-air medium [ 131 and triturated lo-20 times up and down in 
a flame-polished Pasteur pipette of not less than 1 mm aperture. 
Cells were spun (setting 2 for 3 min, Denley microfuge), 
resuspended in -30 yl plating medium and plated in 1~1 drops 
onto the center of 12 mm coverslips that had been coated with 
0.15 OD collagen (&a) [14]. Cells were grown in LlS-CO2 [13] 
containing 20 ,uM cy-tosine arabinoside, 10 ,uM each of uridine 
and fluorodeoxy-uridine, 3% rat serum and 20 ng/ml 2.5 S 
NGF. Although ARA-C has been shown to inhibit the survival- 
promoting actions of NGF on sensory and cihary ganglion 
neurons [15], its presence in the growth medium did not affect 
neuronal survival, probably because there is sufficiently high 
levels of 2-deoxycytidine in the rat serum. 
Cells were labelled with [“H]Ade ]9] for 15-24 h. Samples of 
medium (20 cl) were removed to assess total uptake, coverslips 
were blotted onto tissue [9] and washed in bacteriological grade 
dishes (Sterilin, UK) 3 times in 10 ml L&air medium heated at 
37°C 10 min per wash. The Sterilin plastic bound and effec- 
tively depleted all the dissociable NGF and growth medium 
preincubated in Sterilin dishes was unable to support neurite 
outgrowth on freshly derived neurons or explants. Degenera- 
tion of single cell and explant cultures after incubation in 
Sterilin dishes was similar to those obtained with anti-2.4 S 
NGF antibody (Amersham International ptc) used at concentra- 
tions that block NGF action. To measure purine efflux, 
coverslips were put into wells cont~ning 400-500~1 medium 
and 25 ~1 were removed at various times into 1 ml of 0.1 N 
HCI. At the end of the experiment, coverslips were washed 
briefly in LlS-air and the remaining radioactivity in the cells 
was extracted in 1 ml of 0.1 N HCI. Radioactivity was 
measured by adding 3.5 ml scintillant (Beckman MS). The 
distribution of label in nucleotides, nucleosides and bases was 
measured as described previously [9]. 8-(4”Chlorphenyl-thio) 
CAMP (CPTcAMP) was obtained from Boehringer Corpora- 
tion. Colchicine (COL), 2-deoxyglucose (dGlc), cycloheximide 
(CH) and tosyl-L-lysine chloromethyl ketone (TLCK) were 
from Sigma Chemical Co. 
3. RESULTS 
3.1. Purine efflux from NGF-deprived neurons 
A time course of release of 13H]purines from 
neurons grown for 1 week in medium containing 
20 ng/ml NGF and 3% rat serum (full medium), 
preincubated with 10 ,&i/ml [3H]Ade (0.38 /cM) 
and then transferred to NGF-free medium (con- 
taining 3% rat serum) is shown in fig.lA. The 
neurons are shown in the adjacent photograph (at 
7, 26 and 52 h). A significant rise in the rate of 
purine efflux was observed within 3-7 h of NGF 
removal with no apparent morphological change in 
the appearance of the cells. At 26 h there was only 
slight degeneration of neurites yet almost all of the 
label was released. At this time, addition of NGF 
rescued over 80% of the cells (not shown). By 
52 h, neurites had assumed a typical granulated 
appearance and neurons could no longer be 
rescued by NGF. Average values of fractional 
purine release sampled at 6-7 and 24-26 h were 
17.1 & 3 and 40.3 ~?r. 8.7 (full medium) and 37 zt 7.9 
and 82 k 13 (NGF-free medium), respectively (3 
experiments + SD). Similar kinetics of purine 
release in response to NGF dep~vation were ob- 
tained when explants were used instead of single 
cell cultures (data not shown). 
3.2. Validation of the diagnostic value of the 
purine efJrux assay using CPTcAMP 
Survival of sympathetic and sensory neurons can 
also be maintained by cyclic AMP analogues, 
which appear to act via a different mechanism to 
that of NGF [8]. We therefore tested whether 
purine efflux would remain enhanced in the 
presence of CPTcAMP. As shown in fig.lB, the 
rate of efflux of labelled purines was reduced by 
60-80% by adding OS mM CPTcAMP to the 
NGF-free medium and the degeneration of the 
neurites growing in serum was also substantially 
retarded in the presence of CPTcAMP, as reported 
previously 181. Thus, the suppression of enhanced 
purine efflux was not dependent on whether NGF 
or CPTcAMP were the survival-promoting fac- 
tors. In both cases, the rate of early purine efflux 
Fig. 1. Efflux of [“HIpurines from neurons after withdrawal of NGF. (A) Sympathetic neurons (7 days in culture) were labelled for 
20 h, washed and transferred to 500 ~1 NGF-free or full medium containing 384 ng/ml2.5 S NGF. The amount of purines released 
as a fraction of total radioactivity incorporated into the cells at time zero is shown on the ordinate. Coverslips carried an average of 
700-1000 neurons and 40-100 non-neural cells. At the end of the ex~riments non-neural cefls incorporate an average of 119 rt 
72 fmol/coverslip (n = 7, SD), compared to the neurons which incorporated 4869 f 678 fmol/coverslip (n = 7, SD). Initial uptake 
was 8457 * 1029 fmol/coversIip (n = 7, SD). The right hand panel shows photomicrographs of the neurons taken after 7,26 and 52 h 
(magnification x 1480). (B) The experiment was conducted in parallel to.that described in A. CPTcAMP (0.5 mM) was added to the 
withdrawal media. At the end of the experiment neurons in FM contained 2264 fmol/coverslip while those in serum contained 
1836 fmol/coverslip. Photomicrographs were taken after 7, 26 and 52 h (magnification x 1450). 
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and the subsequent degree of degradation were 
closely correlated, although no visible signs of 
neurite degeneration were apparent during the in- 
itial phases of accelerated purine efflux. However, 
although CPTcAMP could replace NGF and sup- 
press enhanced purine efflux when added 12 h 
after the NGF withdrawal, we were unable to ob- 
tain any effect of CPTcAMP when it was added to 
newly plated cultures. This result differs from that 
of Rydel and Greene [8] and may reflect the much 
lower concentration of serum used in our ex- 
periments (3% rat serum) compared to their ex- 
periments (10% horse serum and 5% fetal calf 
serum). 
When CPTcAMP was added to full medium, 
-15% more label was released compared to the 
full medium control and in some instances lipid in- 
clusion bodies accumulated in the cell bodies 
(fig.lB, inset in panel e). None ever appeared in 
cultures in the presence of CPTcAMP in NGF-free 
medium. This finding was not, however, 
reproducible in every culture and the reason for 
this is unclear. 
3.3. A TP degradation is not the primary cause of 
neurite degeneration 
The release of the Ado and Ino per se was not 
the cause of neurite degradation as their release 
could be blocked by p-(nitrobenzyl) thioinosine 
[9,16] with no change in the kinetics of release or 
cellular viability. The only apparent effect of the 
nucleoside-transport blocker was that almost all of 
the label appeared in hypoxanthine, as expected 
191. Since it was shown [9] that between 2/3 and 
3/4 of metabolically labelled ATP from Ade is 
localised in neurites when they are -5-6 mm long 
(after -1 week) [9], and considering that ATP 
utilisation is vital for neurite function [lo-121, the 
question arose whether the loss of ATP from the 
neurites was the primary cause of neurite degenera- 
tion. To examine this question neurons were ex- 
posed to dGlc which indirectly generates 
AMP/IMP from ATP and consequently enhances 
purine efflux 191. Although 20 mM dGlc in full 
medium caused a decrease in steady-state ATP of 
5-15%, and accelerated purine efflux, there was 
no effect on neurite integrity during the time 
neurites normally degraded in NGF-free medium. 
Thus, the average fraction of Iabel remaining in 
the neurons 19 h after transfer of 4 day cultures in- 
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to NGF-free medium or full medium supplemented 
with dGlc was 18.8% and 14.3% compared to 
39.3% in NGF-free medium containing 
CPTcAMP (triplicates had less than 10% error), 
yet only in the NGF-free medium did the neurites 
become degraded. These results suggest that a
decrease of 5-15% in ATP is insufficient to cause 
neurite degeneration and the breakdown of ATP is 
secondary to some other process. 
3.4. Other effecters of purine efflux 
To extend the correlation between enhanced 
purine efflux and subsequent degeneration and to 
study what may cause ATP degradation we expos- 
ed neurons to CH, which delays neuronal death 
after removal of NGF [7] and should thus delay 
purine efflux. Neurons were also exposed to 
20 mM MgClz which can block calcium entry in 
sympathetic neurons [17,18] and to TLCK to in- 
hibit proteases, as suggested by Baker [19]. The ef- 
fect of COL, which accelerates neurite 
degeneration, was also examined. The addition of 
CH blocked the purine release in the absence of 
NGF, and only slight neurite degradation was ap- 
parent up to 48 h (8 independent experiments). 
MgC12 and TLCK both delayed purine release by 
about 10 h (2 experiments) and prolonged the life 
time of the neurites in NGF-free medium by about 
12-24 h after which the rate of purine efflux rose, 
assuming the enhanced rate observed in NGF-free 
medium and neurites degraded irreversibly. On the 
other hand, COL accelerated purine release by 
2-3-fold (4 experiments), nearly doubling the rate 
of neurite degradation in the presence of NGF. 
The effects of NGF deprivation and COL on 
purine efflux were additive. The results are sum- 
marised in fig.2 which shows the fold increase in 
purine efflux at 10 h compared to that found 
without any additions to the medium with NGF 
and is related to the presence or absence of neurite 
degeneration at 24 h. 
The possibility that ARA-C, normally present in 
our medium, may enhance purine efflux in the 
absence of NGF was also tested. After 11 h in 
NGF-free medium, efflux increased 1.63 it 
0.06-fold in the absence of ARA-C and 1.82 f 
0.08-fold in the presence of ARA-C (n = 3, SD) 
with no apparent change in cellular morphology 
compared to cultures containing NGF. This sug- 
gests that ARA-C has no effect on purine efflux, 
Volume 255, number 2 FEBSLETTERS September 1989 
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Fig.2. Effect of different additives on purine efflux and neurite 
degeneration. The fold efflux of purines after IO h exposure to 
the different conditions is shown compared to that found 
without additions in medium plus NGF. The presence or 
absence of neurite degeneration at 24 h is also indicated. 
probably due to the rat serum containing sufficient 
2-deoxycytidine to inhibit any effects of ARA-C 
H.51. 
4. DISCUSSION 
The acceleration of purine efflux from establish- 
ed, growing neurons is one of the earliest 
biochemical changes that have been reported to oc- 
cur as a result of NGF withdrawal. The enhanced 
purine efflux precedes visible degenerative mor- 
phological changes and can be measured several 
hours before the reported appearance of adenylate 
kinase activity in the medium [7]. Measurement of 
purine efflux can thus provide the basis for a 
noninvasive assay which tests the ability of factors 
to promote the survival of NGF-dependent 
neurons in the absence of NGF. This conclusion is 
supported by the observation that enhanced purine 
efflux can be arrested by re-adding NGF, and that 
CPTcAMP and CH, which prevent neurite 
degeneration [7,8], retard purine efflux in the 
absence of NGF. 
There are clearly multiple pathways promoting 
neuronal survival, as has been shown with CAMP 
analogues which act via different mechanisms to 
- CH TLCK Mg*+ COL 2DG 
NGF - - - - + + 
NeuriteSurvival _ + + + _ + 
After 24 h 
NGF in primary neurons [S], in chromaffin cells 
[20] or in PC12 cells 121-243. CPTcAMP may be 
acting in conjunction with serum factors to 
stabilise NGF-induced proteins localised in the 
neurites. Such an action would explain why the ef- 
ficacy of CPTcAMP in prolonging the life of 
neurons deprived of NGF increases with the age of 
the cultures, along with the enhanced capacity for 
survival of older neurons bearing longer neurites 
(results not shown). This protein could be the NGF 
receptor, or, perhaps, a cytoskeletal-associated 
protein [23]. The amount of CPTcAMP in the 
cells, however, is much higher than the amounts of 
CAMP that can accumulate upon stimulation of 
adenylate cyclase in the absence of drugs that 
block phosphodiesterase activity (Suidan and 
Tolkovsky, unpublished). Thus the physiological 
relevance of this action of CAMP action remains to 
be explored. 
An important question is whether the reduction 
in ATP and the consequent purine efflux as a 
result of NGF withdrawal is directly relevant o the 
mechanism of neurite degeneration. The observa- 
tion that the rate of purine efflux can be uncoupled 
from the rate of neurite degradation with dGlc sug- 
gests that a reduction in ATP does not necessarily 
promote neurite degeneration. However, the abili- 
ty of MgClz and TLCK to delay the rise in purine 
efflux and neurite degradation caused by the 
absence of NGF, but not that caused by the 
presence of dGlc, suggests that the ATP 
breakdown induced by NGF withdrawal may have 
some physiological significance. It has been shown 
that ATP gradients within cells can change coor- 
dinately with cytoskeletal rearrangement [25,26] 
and that calcium causes changes in cytoskeletal 
elements [27-291. The results obtained with MgClz 
and TLCK suggesting indirectly that there may be 
a slow rise in calcium as a result of NGF 
withdrawal are being examined in detail. 
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